Gag-Pol Transframe Domain p6*Is Essential for HIV-1 Protease-Mediated Virus Maturation

被引:11
|
作者
Yu, Fu-Hsien [1 ,2 ]
Chou, Ting-An [3 ]
Liao, Wei-Hao
Huang, Kuo-Jung [1 ]
Wang, Chin-Tien [1 ,2 ]
机构
[1] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan
[3] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan
来源
PLOS ONE | 2015年 / 10卷 / 06期
关键词
TYPE-1; REVERSE-TRANSCRIPTASE; VIRAL INFECTIVITY; NUCLEOCAPSID PROTEIN; PARTICLE MATURATION; SEQUENCES UPSTREAM; IMMUNODEFICIENCY; POLYPROTEIN; PRECURSOR; MUTANTS; RNA;
D O I
10.1371/journal.pone.0127974
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HIV-1 protease (PR) is encoded by pol, which is initially translated as a Pr160(gag-pol) polyprotein by a ribosomal frameshift event. Within Gag-Pol, truncated p6gag is replaced by a transframe domain (referred to as p6* or p6pol) located directly upstream of PR. p6* has been proposed as playing a role in modulating PR activation. Overlapping reading frames between p6* and p6gag present a challenge to researchers using genetic approaches to studying p6* biological functions. To determine the role of p6* in PR activation without affecting the gag reading frame, we constructed a series of Gag/Gag-Pol expression vectors by duplicating PR with or without p6* between PR pairs, and observed that PR duplication eliminated virus production due to significant Gag cleavage enhancement. This effect was mitigated when p6* was placed between the two PRs. Further, Gag cleavage enhancement was markedly reduced when either one of the two PRs was mutationally inactivated. Additional reduction in Gag cleavage efficiency was noted following the removal of p6* from between the two PRs. The insertion of a NC domain (wild-type or mutant) directly upstream of PR or p6* PR did not significantly improve Gag processing efficiency. With the exception of those containing p6* directly upstream of an active PR, all constructs were either noninfectious or weakly infectious. Our results suggest that (a) p6* is essential for triggering PR activation, (b) p6* has a role in preventing premature virus processing, and (c) the NC domain within Gag-Pol is not a major determinant of PR activation.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease
    Louis, JM
    Dyda, F
    Nashed, NT
    Kimmel, AR
    Davies, DR
    BIOCHEMISTRY, 1998, 37 (08) : 2105 - 2110
  • [2] Contribution of the Gag-Pol transframe domain p6*and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1
    Paulus, C
    Ludwig, C
    Wagner, R
    VIROLOGY, 2004, 330 (01) : 271 - 283
  • [3] Erythrocytes as carriers of antisense PNA addressed against HIV-1 gag-pol transframe domain
    Fraternale, Alessandra
    Paoletti, Maria Filomena
    Casabianca, Anna
    Orlandi, Chiara
    Millo, Enrico
    Balestra, Emanuela
    Damonte, Gianluca
    Perno, Carlo Federico
    Magnani, Mauro
    JOURNAL OF DRUG TARGETING, 2009, 17 (04) : 278 - 285
  • [4] Effects of human immunodeficiency virus type 1 transframe protein p6*mutations on viral protease-mediated Gag processing
    Chiu, Hsu-Chen
    Wang, Fu-Der
    Chen, Yi-Ming Arthur
    Wang, Chin-Tien
    JOURNAL OF GENERAL VIROLOGY, 2006, 87 : 2041 - 2046
  • [5] p6gag domain confers cis HIV-1 Gag-Pol assembly and release capability
    Guo, Ting-Wei
    Yu, Fu-Hsien
    Huang, Kuo-Jung
    Wang, Chin-Tien
    JOURNAL OF GENERAL VIROLOGY, 2016, 97 : 209 - 219
  • [6] A virus-like particle assembly system for probing the HIV-1 Gag-Pol dimerization domain: supporting evidence for reverse transcriptase involvement in protease activation by influencing Gag-Pol/Gag-Pol interaction
    Hsieh, Shih-Han
    Huang, Kuo-Jung
    Wang, Chin-Tien
    JOURNAL OF VIROLOGY, 2025,
  • [7] Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein
    Paulus, C
    Hellebrand, S
    Tessmer, U
    Wolf, H
    Kräusslich, HG
    Wagner, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (31) : 21539 - 21543
  • [8] Persistence of processed HIV-1 Gag and Gag-Pol proteins following treatment with HIV-1 protease inhibitors.
    Speck, RR
    Yu, XF
    Flexner, C
    FASEB JOURNAL, 2000, 14 (04): : A185 - A185
  • [9] Accumulation of HIV-1 Gag and Gag-Pol processing intermediates in the presence of non-peptidomimetic HIV-1 protease inhibitors
    Speck, RR
    Yu, XF
    Flexner, C
    ANTIVIRAL RESEARCH, 2000, 46 (01) : A71 - A71
  • [10] C-Terminal HIV-1 Transframe p6*Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6*Domain
    Yu, Fu-Hsien
    Huang, Kuo-Jung
    Wang, Chin-Tien
    JOURNAL OF VIROLOGY, 2017, 91 (10)